ARCHIVES

ODAC To Advise FDA on First Biosimilars Application Jan. 7

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves HPV Test

April 25, 2003

New Structure Of Divisions Outlined

September 15, 1995

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

Biomedical Research Advocates Temper Budget Requests In View Of War, Deficit.

January 28, 2005

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007

Arsenic Compound Improves Survival Of Adults With APL

February 23, 2007